Lifeboat Foundation

There are many nutritional and delicious benefits of eating lobster. Some of them include protecting heart health, increasing energy, decreasing inflammation, speeding healing, promoting growth, boosting brain functioning and building strong bones. Lobsters are shelled marine creatures which are taking parts of crustaceans. They have the scientific name Homarus nephrops. This scientific name is the North Atlantic variety. This undersea creature is having old look and it is considered to be luxury or delicacy food in many parts of the world. Nowadays lobster is exported to many parts of the world. They are particularly popular in North America. Lobsters are delicious food but they have high prices which is a reason why they are not consumed a lot. It is important to know that the lobster has high amounts of cholesterol and sodium. If you suffer from cardiovascular issues, high blood pressure or any other health condition, then you should not consume lobster because it has minerals and nutrients which are not ideal for these conditions. Every food should be consumed in moderation. Lobster is ideal food for people to get many vitamins and minerals that are essential for their health. People who live in North American coasts can have lobster in every time because here the price of it is very low.

The CRISPR gene-editing system is usually known for helping scientists treat genetic diseases, but the technology has a whole range of possible uses in synthetic biology too. Now researchers at ETH Zurich have used CRISPR to build functional biocomputers inside human cells.

A computer science student has scraped seven million Venmo transactions to prove that users’ public activity can still be easily obtained, a year after a privacy researcher downloaded hundreds of millions of Venmo transactions in a similar feat.

Dan Salmon said he scraped the transactions during a cumulative six months to raise awareness and warn users to set their Venmo payments to private.

The peer-to-peer mobile payments service faced criticism last year after Hang Do Thi Duc, a former Mozilla fellow, downloaded 207 million transactions. The scraping effort was possible because Venmo payments between users are public by default. The scrapable data inspired several new projects — including a bot that tweeted out every time someone bought drugs.

A new gene therapy for a rare blood disorder will sell for €1.6 million ($1.8 million) in Europe, according to the maker of the recently approved treatment, whose sticker price is the latest indication that already high drug costs are continuing to climb.

After it goes on sale, the Zynteglo gene therapy from Bluebird Bio Inc. will be the second-most expensive drug in the world after Novartis’s $2.1 million Zolgensma gene therapy, which was recently approved for sale in the U.S.

The collaboration, its architects say, was designed to carefully address questions familiar to partnerships involving academic and industry scientists.

You may be familiar with bovine spongiform encephalopathy, better known as mad cow disease. Did you know there’s a lesser-known—but similar—illness that affects deer, moose, and elk? It’s called chronic wasting disease, and like mad cow, it is also a brain disease, thought to be caused by a malformed, twisted protein called a prion. CWD leads to unusual behavior, and often results in the animals becoming gruesomely thin before they die. First discovered in 1967, CWD now has been detected in at least 26 states, three Canadian provinces, Norway, Sweden, and South Korea.

Rae Ellen Bichell, a reporter with the Mountain West News Bureau and KUNC, explored chronic wasting disease in a multipart series titled “ Bent Out Of Shape.” She joins Ira to talk about the disease, research into its origin and spread, and what’s known about the possible effects of human exposure to CWD.

Check out the full series.

Sheila Gujrathi has worked as a doctor, a McKinsey consultant, and at an up-and-coming biotech. Each role prepared her to be CEO in different ways.

The experimental Ebola vaccine being used to try to contain the outbreak in the Democratic Republic of the Congo is protective 97.5% of the time.

In a breakthrough that could save thousands of lives, scientists have found a way to convert all blood types to the universal type that is safe for all patients to receive, by using microbes found in the human gut.

Researchers from the University of British Columbia have figured out how to convert blood types A, B and AB into the universal Type O, which all patients can receive in a transfusion, regardless of their own blood type.